An unusual patient with hypothyroidism, tophaceous gout, and marked joint destruction

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 604-607

  Montoya, F ^a   Torres, R J ^a   Fraile, J M ^a   Puig, J G ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Gout; Hyperuricemia; Hypothyroidism; Tophus; Uric acid

Indexed keywords

ALLOPURINOL; ANTIHYPERTENSIVE AGENT; COLCHICINE; CREATININE; DIURETIC AGENT; ORAL ANTIDIABETIC AGENT; PREDNISONE; THYROID HORMONE; URATE;

AGED; ANAMNESIS; ARTHRITIS; CASE REPORT; CAUCASIAN; CLINICAL FEATURE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE INCREASE; FOLLOW UP; GOUT; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; PROPHYLAXIS; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

AGED; GOUT; HUMANS; HYPOTHYROIDISM; JOINTS; MALE; URIC ACID;

EID: 46749123854     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802138418     Document Type: Conference Paper

References (18)

1. Lieber, C.S.; Jones, D.P.; Losowsky, M.S.; Davidson, C.S. Interrelation of uric acid and ethanol metabolism in man. J. Clin. Invest. 1962, 41, 1863-1870.
2. Garcia Puig, J.; Mateos Antón, F.; Fox, I.H. Interrelacion entre el metabolismo del alcohol y el del acido urico. Rev. Clin. Esp. 1983, 171, 301-304.
3. Puig, J.G.; Fox, I.H. Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J. Clin. Invest. 1984, 74, 936-941.
4. Eisen, A.Z.; Seegmiller, J.E. Uric acid metabolism in psoriasis. J. Clin. Invest. 1961, 40, 1486-1494.
5. González Sanz, A.; García Puig, J.; Gómez, P.; Ramos, T.; Mateos, F.; Fonseca, E. Metabolismo del acido urico en la psoriasis. Piel 1989, 4, 305-308.
6. Mateos Anton, F.; Garcia Puig, J.; Gomez Fernandez, P.; Ramos Hernandez, T.; Lopez Jimenez, M. Degradation of purine nucleotides in patients with chronic obstruction to airflow. Med. Clin. (Barc.) 1989, 92, 328-330.
7. Goldman, M. Uric acid in the etiology of psoriasis. Am. J. Dermatopathol. 1981, 3, 397-404.
8. Wolfe, F.; Cathey, M.A. The misdiagnosis of gout and hyperuricemia. J. Rheumatol. 1991, 18, 1232-1234.
9. Messerli, F.H.; Frohlich, D.E.; Dreslinnski, G.R.; Suarez, D.H.; Aristimuno, G.G. Uric acid in essential hypertension: an indicator of renal vascular involvement. Ann. Intern. Med. 1980, 93, 817-821.
10. Puig, J.G.; Ruilope, L.M. Uric acid as a cardiovascular risk factor in arterial hypertension. J. Hypertens. 1999, 17, 869-872.
11. Scott, J.T.; Higgens, C.S. Diuretic induced gout: a multifactorial condition. Ann. Rheum. Dis. 1992, 51, 259-261.
12. Waller, P.C.; Ramsay, L.E. Predicting acute gout in diuretic-treated hypertensive patients. J. Hum. Hypertens. 1989, 3, 457-461.
13. Campion, E.W.; Glynn, R.J.; DeLabry, L.O. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am. J. Med. 1987, 82, 421-426.
14. Lin, K.C.; Lin, H.Y.; Chou, P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J. Rheumatol. 2000, 27, 1045-1050.
15. Erickson, A.R.; Enzenauer, R.J.; Nordstrom, D.M.; Merenich. J/A. The prevalence of hypothyroidism in gout. Am. J. Med. 1994, 97, 231-234.
16. Giordano, N.; Santacroce, C.; Matti, G.; Geraci, S.; Amendola, A, Gennari, C. Hyperuricemia and gout in thyroid endocrine disorders. Clin. Exp. Rheumatol. 2001,19, 661-6655.
17. Keith, M.P.; Gilliland, W.R. Updates in the management of gout. Am. J. Med. 2007,120, 221-224.
18. Terkeltaub, R.A. Gout. N. Engl. J. Med. 2003, 349, 1647-1655.